| 0 |
ISCHAEMIC MITRAL REGURGITATION |
2 |
0.2500 |
| 1 |
IMAGING PROCEDURE ARTIFACT |
3 |
0.1875 |
| 2 |
ADRENAL THROMBOSIS |
3 |
0.1364 |
| 3 |
ARTERIOVENOUS FISTULA, ACQUIRED |
2 |
0.1333 |
| 4 |
AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA |
8 |
0.1270 |
| 5 |
THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME |
5 |
0.1190 |
| 6 |
OESOPHAGEAL INTRAMURAL HAEMATOMA |
8 |
0.0762 |
| 7 |
LIVER TRANSPLANT FAILURE |
3 |
0.0545 |
| 8 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
259 |
0.0525 |
| 9 |
COAGULATION TIME PROLONGED |
77 |
0.0497 |
| 10 |
HEPARIN RESISTANCE |
6 |
0.0492 |
| 11 |
FIBRIN |
2 |
0.0465 |
| 12 |
COAGULATION TIME ABNORMAL |
12 |
0.0400 |
| 13 |
ILIAC ARTERY OCCLUSION |
9 |
0.0327 |
| 14 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL |
8 |
0.0324 |
| 15 |
MEDIASTINAL HAEMORRHAGE |
3 |
0.0309 |
| 16 |
MEDIASTINAL HAEMATOMA |
5 |
0.0301 |
| 17 |
INHIBITING ANTIBODIES |
2 |
0.0286 |
| 18 |
JOINT DEFORMITY |
2 |
0.0267 |
| 19 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED |
10 |
0.0239 |
| 20 |
HEPARIN-INDUCED THROMBOCYTOPENIA TEST POSITIVE |
2 |
0.0238 |
| 21 |
COLONIC HAEMATOMA |
2 |
0.0235 |
| 22 |
VASCULAR STENT THROMBOSIS |
47 |
0.0231 |
| 23 |
CEREBRAL HYPERPERFUSION SYNDROME |
2 |
0.0220 |
| 24 |
CONTRAST ENCEPHALOPATHY |
6 |
0.0217 |
| 25 |
CARDIAC PROCEDURE COMPLICATION |
13 |
0.0214 |
| 26 |
THORACIC HAEMORRHAGE |
4 |
0.0200 |
| 27 |
HAEMORRHAGIC CEREBRAL INFARCTION |
14 |
0.0199 |
| 28 |
VASCULAR STENT OCCLUSION |
8 |
0.0199 |
| 29 |
VASCULAR ACCESS SITE HAEMORRHAGE |
3 |
0.0186 |
| 30 |
MEDICAL DEVICE SITE HAEMORRHAGE |
5 |
0.0176 |
| 31 |
MICROEMBOLISM |
2 |
0.0175 |
| 32 |
INFERIOR VENA CAVAL OCCLUSION |
2 |
0.0174 |
| 33 |
DRY GANGRENE |
11 |
0.0173 |
| 34 |
ACHROMOBACTER INFECTION |
2 |
0.0167 |
| 35 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
83 |
0.0164 |
| 36 |
BURKHOLDERIA TEST POSITIVE |
2 |
0.0161 |
| 37 |
CONGENITAL ARTERIAL MALFORMATION |
3 |
0.0156 |
| 38 |
PRODUCT BARCODE ISSUE |
6 |
0.0155 |
| 39 |
RENAL VEIN THROMBOSIS |
10 |
0.0148 |
| 40 |
MYOCARDIAL STRAIN |
2 |
0.0144 |
| 41 |
HEPATIC ARTERY THROMBOSIS |
4 |
0.0137 |
| 42 |
THROMBOSIS IN DEVICE |
44 |
0.0134 |
| 43 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
35 |
0.0134 |
| 44 |
VASCULAR PSEUDOANEURYSM |
23 |
0.0132 |
| 45 |
CARDIAC VENTRICULAR THROMBOSIS |
17 |
0.0132 |
| 46 |
VENOUS STENOSIS |
3 |
0.0119 |
| 47 |
PUNCTURE SITE HAEMORRHAGE |
8 |
0.0113 |
| 48 |
OPERATIVE HAEMORRHAGE |
5 |
0.0112 |
| 49 |
THERAPEUTIC PRODUCT EFFECT PROLONGED |
5 |
0.0110 |
| 50 |
THROMBOTIC CEREBRAL INFARCTION |
4 |
0.0106 |
| 51 |
ANASTOMOTIC HAEMORRHAGE |
2 |
0.0105 |
| 52 |
HYPOFIBRINOGENAEMIA |
10 |
0.0101 |
| 53 |
ARTERY DISSECTION |
4 |
0.0097 |
| 54 |
HAEMORRHAGIC INFARCTION |
5 |
0.0091 |
| 55 |
COAGULATION TIME SHORTENED |
3 |
0.0090 |
| 56 |
ADRENAL HAEMORRHAGE |
5 |
0.0089 |
| 57 |
FALSE NEGATIVE INVESTIGATION RESULT |
6 |
0.0085 |
| 58 |
TRACHEAL HAEMORRHAGE |
3 |
0.0085 |
| 59 |
VENA CAVA THROMBOSIS |
14 |
0.0084 |
| 60 |
CEREBRAL VENOUS SINUS THROMBOSIS |
7 |
0.0083 |
| 61 |
PHARYNGEAL HAEMORRHAGE |
10 |
0.0081 |
| 62 |
AXILLARY VEIN THROMBOSIS |
3 |
0.0081 |
| 63 |
CATHETER SITE HAEMORRHAGE |
20 |
0.0080 |
| 64 |
PERIPHERAL ARTERY THROMBOSIS |
11 |
0.0078 |
| 65 |
MESENTERIC ARTERY THROMBOSIS |
3 |
0.0078 |
| 66 |
GASTROINTESTINAL LYMPHOMA |
2 |
0.0077 |
| 67 |
HAEMORRHAGIC TRANSFORMATION STROKE |
11 |
0.0073 |
| 68 |
CARDIAC VENTRICULAR DISORDER |
3 |
0.0073 |
| 69 |
ARTERIAL THROMBOSIS LIMB |
3 |
0.0072 |
| 70 |
FISTULA OF SMALL INTESTINE |
3 |
0.0072 |
| 71 |
PELVIC VENOUS THROMBOSIS |
10 |
0.0070 |
| 72 |
AORTIC THROMBOSIS |
8 |
0.0069 |
| 73 |
RETROPERITONEAL HAEMORRHAGE |
17 |
0.0069 |
| 74 |
PERICARDIAL HAEMORRHAGE |
15 |
0.0069 |
| 75 |
CATHETER SITE HAEMATOMA |
2 |
0.0068 |
| 76 |
MESENTERIC PANNICULITIS |
2 |
0.0067 |
| 77 |
POST THROMBOTIC SYNDROME |
3 |
0.0067 |
| 78 |
EMBOLISM ARTERIAL |
8 |
0.0067 |
| 79 |
KOUNIS SYNDROME |
15 |
0.0066 |
| 80 |
CORONARY ARTERY THROMBOSIS |
13 |
0.0064 |
| 81 |
BRONCHIAL HAEMORRHAGE |
2 |
0.0064 |
| 82 |
CHRONIC HEPATITIS B |
2 |
0.0063 |
| 83 |
PERFORATION |
5 |
0.0062 |
| 84 |
RUPTURED CEREBRAL ANEURYSM |
4 |
0.0062 |
| 85 |
INCISION SITE HAEMORRHAGE |
5 |
0.0062 |
| 86 |
ABDOMINAL WALL HAEMATOMA |
12 |
0.0061 |
| 87 |
ARTHRITIS ENTEROPATHIC |
2 |
0.0061 |
| 88 |
ARTERIOVENOUS FISTULA |
3 |
0.0061 |
| 89 |
ISCHAEMIC HEPATITIS |
8 |
0.0058 |
| 90 |
FAT EMBOLISM |
2 |
0.0056 |
| 91 |
GLOMERULONEPHRITIS PROLIFERATIVE |
2 |
0.0055 |
| 92 |
RIGHT VENTRICULAR DYSFUNCTION |
6 |
0.0054 |
| 93 |
LUNG INFECTION PSEUDOMONAL |
3 |
0.0054 |
| 94 |
KLEBSIELLA SEPSIS |
6 |
0.0053 |
| 95 |
HEPATIC INFARCTION |
2 |
0.0053 |
| 96 |
ANTIPHOSPHOLIPID ANTIBODIES POSITIVE |
3 |
0.0052 |
| 97 |
CEREBRAL ARTERIOSCLEROSIS |
2 |
0.0052 |
| 98 |
EXTREMITY NECROSIS |
9 |
0.0052 |
| 99 |
HYPOCOAGULABLE STATE |
5 |
0.0051 |
| 100 |
CEREBELLAR STROKE |
2 |
0.0051 |
| 101 |
DEVICE RELATED THROMBOSIS |
5 |
0.0051 |
| 102 |
PERIPHERAL ISCHAEMIA |
20 |
0.0049 |
| 103 |
TERMINAL ILEITIS |
3 |
0.0049 |
| 104 |
HYPERCHLORAEMIA |
3 |
0.0047 |
| 105 |
ANOXIC ENCEPHALOPATHY |
3 |
0.0047 |
| 106 |
PULMONARY ALVEOLAR HAEMORRHAGE |
26 |
0.0046 |
| 107 |
JUGULAR VEIN THROMBOSIS |
8 |
0.0045 |
| 108 |
ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL |
2 |
0.0045 |
| 109 |
FEEDING INTOLERANCE |
2 |
0.0044 |
| 110 |
SUBCLAVIAN VEIN THROMBOSIS |
5 |
0.0044 |
| 111 |
BLOOD FIBRINOGEN DECREASED |
5 |
0.0044 |
| 112 |
ANEURYSM RUPTURED |
4 |
0.0044 |
| 113 |
PANCREATITIS HAEMORRHAGIC |
2 |
0.0043 |
| 114 |
HAEMOTHORAX |
12 |
0.0041 |
| 115 |
EVANS SYNDROME |
2 |
0.0041 |
| 116 |
INTERNATIONAL NORMALISED RATIO INCREASED |
115 |
0.0040 |
| 117 |
MUCOSAL ULCERATION |
4 |
0.0040 |
| 118 |
BRAIN STEM INFARCTION |
4 |
0.0039 |
| 119 |
ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC |
3 |
0.0039 |
| 120 |
CEREBRAL ARTERY THROMBOSIS |
2 |
0.0039 |
| 121 |
SKIN NECROSIS |
20 |
0.0039 |
| 122 |
PROCEDURAL HAEMORRHAGE |
14 |
0.0036 |
| 123 |
CARDIAC TAMPONADE |
17 |
0.0036 |
| 124 |
ENCEPHALOMALACIA |
2 |
0.0036 |
| 125 |
INTRACRANIAL HAEMATOMA |
2 |
0.0036 |
| 126 |
PNEUMATOSIS INTESTINALIS |
10 |
0.0035 |
| 127 |
SICK SINUS SYNDROME |
4 |
0.0035 |
| 128 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
5 |
0.0035 |
| 129 |
MUCOSAL HAEMORRHAGE |
4 |
0.0034 |
| 130 |
SUBARACHNOID HAEMORRHAGE |
35 |
0.0034 |
| 131 |
UPPER AIRWAY OBSTRUCTION |
3 |
0.0034 |
| 132 |
HAEMATOMA MUSCLE |
4 |
0.0033 |
| 133 |
GANGRENE |
20 |
0.0033 |
| 134 |
BLEEDING TIME PROLONGED |
4 |
0.0033 |
| 135 |
COAGULOPATHY |
55 |
0.0033 |
| 136 |
WRONG SCHEDULE |
3 |
0.0031 |
| 137 |
ABDOMINAL COMPARTMENT SYNDROME |
2 |
0.0031 |
| 138 |
DISSEMINATED INTRAVASCULAR COAGULATION |
44 |
0.0031 |
| 139 |
CONTINUOUS HAEMODIAFILTRATION |
3 |
0.0031 |
| 140 |
GASTROINTESTINAL MUCOSAL DISORDER |
2 |
0.0031 |
| 141 |
ACUTE LEFT VENTRICULAR FAILURE |
2 |
0.0030 |
| 142 |
POST PROCEDURAL HAEMATOMA |
5 |
0.0030 |
| 143 |
CEREBELLAR INFARCTION |
5 |
0.0030 |
| 144 |
CARDIOGENIC SHOCK |
42 |
0.0029 |
| 145 |
VENOUS THROMBOSIS LIMB |
6 |
0.0029 |
| 146 |
ATRIAL THROMBOSIS |
6 |
0.0029 |
| 147 |
PRODUCT TASTE ABNORMAL |
39 |
0.0029 |
| 148 |
PROTHROMBIN TIME SHORTENED |
4 |
0.0029 |
| 149 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
13 |
0.0028 |
| 150 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
2 |
0.0028 |
| 151 |
DELAYED GRAFT FUNCTION |
2 |
0.0028 |
| 152 |
ALANINE AMINOTRANSFERASE DECREASED |
2 |
0.0028 |
| 153 |
ARRHYTHMIA SUPRAVENTRICULAR |
3 |
0.0027 |
| 154 |
FINGER AMPUTATION |
2 |
0.0027 |
| 155 |
CORNEAL DEPOSITS |
2 |
0.0027 |
| 156 |
PULMONARY HAEMORRHAGE |
21 |
0.0027 |
| 157 |
ARTERIAL INJURY |
2 |
0.0027 |
| 158 |
CATHETER SITE RELATED REACTION |
2 |
0.0027 |
| 159 |
EMBOLISM VENOUS |
8 |
0.0026 |
| 160 |
ARTERIAL HAEMORRHAGE |
3 |
0.0026 |
| 161 |
HYPERCOAGULATION |
5 |
0.0026 |
| 162 |
PUPILS UNEQUAL |
3 |
0.0026 |
| 163 |
PERIPHERAL EMBOLISM |
3 |
0.0026 |
| 164 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
23 |
0.0026 |
| 165 |
ARTERIAL THROMBOSIS |
5 |
0.0026 |
| 166 |
VENTRICULAR FIBRILLATION |
28 |
0.0025 |
| 167 |
ANTIPHOSPHOLIPID SYNDROME |
4 |
0.0025 |
| 168 |
CARDIAC DEATH |
3 |
0.0025 |
| 169 |
HAEMORRHAGE INTRACRANIAL |
37 |
0.0025 |
| 170 |
PRODUCT PACKAGING CONFUSION |
6 |
0.0025 |
| 171 |
CEREBRAL INFARCTION |
59 |
0.0024 |
| 172 |
PROTHROMBIN TIME PROLONGED |
14 |
0.0023 |
| 173 |
SHOCK HAEMORRHAGIC |
19 |
0.0023 |
| 174 |
HEPATIC HAEMORRHAGE |
2 |
0.0023 |
| 175 |
CORONARY ARTERY DISSECTION |
2 |
0.0023 |
| 176 |
PUPIL FIXED |
4 |
0.0023 |
| 177 |
ABDOMINAL LYMPHADENOPATHY |
2 |
0.0023 |
| 178 |
STAPHYLOCOCCAL BACTERAEMIA |
10 |
0.0023 |
| 179 |
COMPARTMENT SYNDROME |
6 |
0.0023 |
| 180 |
VENOUS THROMBOSIS |
9 |
0.0023 |
| 181 |
HYPERLEUKOCYTOSIS |
2 |
0.0023 |
| 182 |
PARVOVIRUS B19 INFECTION |
2 |
0.0022 |
| 183 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
2 |
0.0022 |
| 184 |
SUBDURAL HAEMORRHAGE |
6 |
0.0022 |
| 185 |
TOXIC EPIDERMAL NECROLYSIS |
33 |
0.0022 |
| 186 |
PULSELESS ELECTRICAL ACTIVITY |
9 |
0.0022 |
| 187 |
BRONCHIAL OBSTRUCTION |
3 |
0.0021 |
| 188 |
PERIPHERAL ARTERY OCCLUSION |
3 |
0.0021 |
| 189 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
7 |
0.0021 |
| 190 |
NEUTROPENIC INFECTION |
2 |
0.0021 |
| 191 |
RENAL INFARCT |
3 |
0.0021 |
| 192 |
POST PROCEDURAL HAEMORRHAGE |
24 |
0.0021 |
| 193 |
CROSS SENSITIVITY REACTION |
2 |
0.0021 |
| 194 |
EMBOLISM |
17 |
0.0020 |
| 195 |
GASTROINTESTINAL WALL THICKENING |
3 |
0.0020 |
| 196 |
RIGHT VENTRICULAR FAILURE |
14 |
0.0020 |
| 197 |
EMBOLIC STROKE |
7 |
0.0020 |
| 198 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
3 |
0.0020 |
| 199 |
FALSE POSITIVE INVESTIGATION RESULT |
2 |
0.0020 |
| 200 |
CATHETER RELATED INFECTION |
2 |
0.0020 |
| 201 |
AUTISM |
2 |
0.0020 |
| 202 |
FIBRIN D DIMER INCREASED |
7 |
0.0020 |
| 203 |
INJECTION SITE NECROSIS |
4 |
0.0020 |
| 204 |
ENDOCARDITIS |
10 |
0.0019 |
| 205 |
ENTEROCOCCAL BACTERAEMIA |
2 |
0.0019 |
| 206 |
HAEMODYNAMIC INSTABILITY |
14 |
0.0018 |
| 207 |
BLADDER DILATATION |
2 |
0.0018 |
| 208 |
GASTROINTESTINAL TRACT IRRITATION |
2 |
0.0018 |
| 209 |
INTESTINAL ISCHAEMIA |
10 |
0.0018 |
| 210 |
ADENOCARCINOMA |
4 |
0.0018 |
| 211 |
CATHETER RELATED COMPLICATION |
2 |
0.0018 |
| 212 |
GAZE PALSY |
3 |
0.0018 |
| 213 |
HAEMORRHAGE |
184 |
0.0018 |
| 214 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
6 |
0.0017 |
| 215 |
MULTI-ORGAN FAILURE |
30 |
0.0017 |
| 216 |
ISCHAEMIC CEREBRAL INFARCTION |
2 |
0.0017 |
| 217 |
INTRA-ABDOMINAL HAEMORRHAGE |
4 |
0.0017 |
| 218 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
2 |
0.0017 |
| 219 |
DIABETES INSIPIDUS |
4 |
0.0017 |
| 220 |
INTRACARDIAC THROMBUS |
5 |
0.0016 |
| 221 |
BRAIN DEATH |
5 |
0.0016 |
| 222 |
AMPUTATION |
2 |
0.0016 |
| 223 |
MECHANICAL VENTILATION |
3 |
0.0016 |
| 224 |
MALLORY-WEISS SYNDROME |
2 |
0.0016 |
| 225 |
APGAR SCORE LOW |
2 |
0.0016 |
| 226 |
IATROGENIC INJURY |
2 |
0.0016 |
| 227 |
PRODUCT LABEL CONFUSION |
9 |
0.0015 |
| 228 |
BICYTOPENIA |
3 |
0.0015 |
| 229 |
INFUSION SITE HAEMORRHAGE |
5 |
0.0015 |
| 230 |
PACKED RED BLOOD CELL TRANSFUSION |
2 |
0.0015 |
| 231 |
ANORECTAL DISCOMFORT |
8 |
0.0015 |
| 232 |
EAR HAEMORRHAGE |
3 |
0.0015 |
| 233 |
INTERNATIONAL NORMALISED RATIO DECREASED |
6 |
0.0015 |
| 234 |
GASTRIC HAEMORRHAGE |
17 |
0.0015 |
| 235 |
ECHOCARDIOGRAM ABNORMAL |
2 |
0.0014 |
| 236 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
2 |
0.0014 |
| 237 |
ACUTE MYOCARDIAL INFARCTION |
42 |
0.0014 |
| 238 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
5 |
0.0014 |
| 239 |
TONGUE DISCOMFORT |
6 |
0.0014 |
| 240 |
CEREBELLAR HAEMORRHAGE |
2 |
0.0014 |
| 241 |
CEREBRAL HAEMORRHAGE |
50 |
0.0014 |
| 242 |
OESOPHAGEAL VARICES HAEMORRHAGE |
3 |
0.0014 |
| 243 |
FOOT AMPUTATION |
2 |
0.0014 |
| 244 |
VENTRICULAR ARRHYTHMIA |
5 |
0.0014 |
| 245 |
HAEMORRHAGIC ANAEMIA |
6 |
0.0014 |
| 246 |
RETROPERITONEAL HAEMATOMA |
3 |
0.0014 |
| 247 |
ENTEROCOLITIS HAEMORRHAGIC |
2 |
0.0014 |
| 248 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
38 |
0.0013 |
| 249 |
BRAIN HERNIATION |
4 |
0.0013 |
| 250 |
DISTRIBUTIVE SHOCK |
3 |
0.0013 |
| 251 |
THROMBOPHLEBITIS SUPERFICIAL |
4 |
0.0013 |
| 252 |
ISCHAEMIA |
6 |
0.0013 |
| 253 |
PROCEDURAL COMPLICATION |
10 |
0.0013 |
| 254 |
DUODENITIS |
4 |
0.0013 |
| 255 |
NEUROLOGICAL DECOMPENSATION |
3 |
0.0013 |
| 256 |
HAEMORRHAGIC STROKE |
10 |
0.0013 |
| 257 |
DEEP VEIN THROMBOSIS |
83 |
0.0013 |
| 258 |
THROMBOSIS |
102 |
0.0013 |
| 259 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
2 |
0.0013 |
| 260 |
ANGIOPATHY |
7 |
0.0012 |
| 261 |
LEG AMPUTATION |
5 |
0.0012 |
| 262 |
INTRAVENTRICULAR HAEMORRHAGE |
3 |
0.0012 |
| 263 |
PRODUCT USE COMPLAINT |
19 |
0.0012 |
| 264 |
PEPTIC ULCER |
4 |
0.0012 |
| 265 |
HAEMATOMA |
31 |
0.0012 |
| 266 |
INCORRECT DRUG ADMINISTRATION RATE |
5 |
0.0012 |
| 267 |
DRUG RESISTANCE |
30 |
0.0012 |
| 268 |
CEREBRAL ISCHAEMIA |
6 |
0.0012 |
| 269 |
GASTROINTESTINAL HAEMORRHAGE |
97 |
0.0012 |
| 270 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
3 |
0.0011 |
| 271 |
HAEMATEMESIS |
29 |
0.0011 |
| 272 |
ATELECTASIS |
11 |
0.0011 |
| 273 |
LUNG INFILTRATION |
10 |
0.0011 |
| 274 |
INTRA-ABDOMINAL FLUID COLLECTION |
2 |
0.0011 |
| 275 |
ABDOMINAL RIGIDITY |
3 |
0.0011 |
| 276 |
HEMIPLEGIA |
9 |
0.0011 |
| 277 |
NECROSIS |
6 |
0.0011 |
| 278 |
INTRACRANIAL PRESSURE INCREASED |
6 |
0.0011 |
| 279 |
ENDOTRACHEAL INTUBATION |
3 |
0.0011 |
| 280 |
ISCHAEMIC STROKE |
19 |
0.0011 |
| 281 |
PULSE ABSENT |
5 |
0.0011 |
| 282 |
DUODENAL ULCER HAEMORRHAGE |
3 |
0.0010 |
| 283 |
ADRENAL DISORDER |
2 |
0.0010 |
| 284 |
COLITIS ISCHAEMIC |
7 |
0.0010 |
| 285 |
COMA SCALE ABNORMAL |
3 |
0.0010 |
| 286 |
VENTRICULAR TACHYCARDIA |
17 |
0.0010 |
| 287 |
BRAIN OEDEMA |
13 |
0.0010 |
| 288 |
HYPERAEMIA |
2 |
0.0010 |
| 289 |
GASTROINTESTINAL SOUNDS ABNORMAL |
5 |
0.0010 |
| 290 |
HYPERCAPNIA |
3 |
0.0010 |
| 291 |
PERICARDIAL EFFUSION |
23 |
0.0010 |
| 292 |
ORGAN FAILURE |
4 |
0.0010 |
| 293 |
RETCHING |
21 |
0.0010 |
| 294 |
EYELID PAIN |
2 |
0.0010 |
| 295 |
DYSAESTHESIA |
3 |
0.0010 |
| 296 |
FIBROSIS |
3 |
0.0010 |
| 297 |
CHANGE OF BOWEL HABIT |
2 |
0.0010 |
| 298 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 299 |
INTERNATIONAL NORMALISED RATIO FLUCTUATION |
2 |
0.0010 |
| 300 |
LIVEDO RETICULARIS |
2 |
0.0010 |
| 301 |
MOUTH HAEMORRHAGE |
7 |
0.0010 |
| 302 |
FOREIGN BODY IN THROAT |
3 |
0.0010 |
| 303 |
EAR SWELLING |
2 |
0.0009 |
| 304 |
VENTRICULAR HYPOKINESIA |
3 |
0.0009 |
| 305 |
PROCTALGIA |
6 |
0.0009 |
| 306 |
HYPERPHOSPHATAEMIA |
2 |
0.0009 |
| 307 |
FACIAL PALSY |
2 |
0.0009 |
| 308 |
MELAENA |
20 |
0.0009 |
| 309 |
SUBDURAL HAEMATOMA |
13 |
0.0009 |
| 310 |
ATRIOVENTRICULAR BLOCK COMPLETE |
6 |
0.0009 |
| 311 |
PULMONARY EMBOLISM |
85 |
0.0009 |
| 312 |
SUPRAVENTRICULAR EXTRASYSTOLES |
3 |
0.0009 |
| 313 |
BLOOD LOSS ANAEMIA |
2 |
0.0009 |
| 314 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
2 |
0.0009 |
| 315 |
APLASIA PURE RED CELL |
3 |
0.0009 |
| 316 |
PNEUMONIA BACTERIAL |
8 |
0.0009 |
| 317 |
LEFT VENTRICULAR FAILURE |
3 |
0.0009 |
| 318 |
SHOCK |
20 |
0.0009 |
| 319 |
HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0009 |
| 320 |
ELECTROLYTE IMBALANCE |
10 |
0.0009 |
| 321 |
HYPOVOLAEMIA |
5 |
0.0009 |
| 322 |
THROMBOCYTOPENIA |
95 |
0.0008 |
| 323 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
15 |
0.0008 |
| 324 |
HAEMORRHAGIC DIATHESIS |
3 |
0.0008 |
| 325 |
HYPOVOLAEMIC SHOCK |
4 |
0.0008 |
| 326 |
INFLAMMATORY MARKER INCREASED |
4 |
0.0008 |
| 327 |
PURPURA |
7 |
0.0008 |
| 328 |
HAEMOPTYSIS |
22 |
0.0008 |
| 329 |
HAEMORRHAGE URINARY TRACT |
2 |
0.0008 |
| 330 |
INCREASED BRONCHIAL SECRETION |
2 |
0.0008 |
| 331 |
POST PROCEDURAL COMPLICATION |
15 |
0.0008 |
| 332 |
ACUTE RESPIRATORY FAILURE |
15 |
0.0008 |
| 333 |
ABNORMAL UTERINE BLEEDING |
2 |
0.0008 |
| 334 |
OESOPHAGEAL DISORDER |
3 |
0.0008 |
| 335 |
DIALYSIS |
11 |
0.0008 |
| 336 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
13 |
0.0008 |
| 337 |
MUCORMYCOSIS |
2 |
0.0008 |
| 338 |
CHOKING |
15 |
0.0008 |
| 339 |
PULMONARY HYPERTENSION |
16 |
0.0008 |
| 340 |
HYPOXIA |
27 |
0.0008 |
| 341 |
RESPIRATORY ACIDOSIS |
3 |
0.0008 |
| 342 |
EXFOLIATIVE RASH |
2 |
0.0008 |
| 343 |
CARDIAC FAILURE ACUTE |
5 |
0.0007 |
| 344 |
AREFLEXIA |
2 |
0.0007 |
| 345 |
GASTROINTESTINAL INJURY |
2 |
0.0007 |
| 346 |
CARDIAC ARREST |
61 |
0.0007 |
| 347 |
GASTRIC PERFORATION |
2 |
0.0007 |
| 348 |
INFARCTION |
5 |
0.0007 |
| 349 |
GASTRIC ULCER HAEMORRHAGE |
4 |
0.0007 |
| 350 |
ORAL DISCOMFORT |
10 |
0.0007 |
| 351 |
HAEMODIALYSIS |
6 |
0.0007 |
| 352 |
SEPTIC SHOCK |
31 |
0.0007 |
| 353 |
IMMUNE THROMBOCYTOPENIC PURPURA |
2 |
0.0007 |
| 354 |
NEUTROPENIC SEPSIS |
5 |
0.0007 |
| 355 |
RESPIRATORY FAILURE |
51 |
0.0007 |
| 356 |
PNEUMOTHORAX |
11 |
0.0007 |
| 357 |
FAECES DISCOLOURED |
15 |
0.0007 |
| 358 |
STRESS CARDIOMYOPATHY |
4 |
0.0007 |
| 359 |
RENAL FAILURE ACUTE |
29 |
0.0007 |
| 360 |
HYPERTRIGLYCERIDAEMIA |
4 |
0.0007 |
| 361 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 362 |
IRON DEFICIENCY |
3 |
0.0007 |
| 363 |
ANAL INCONTINENCE |
6 |
0.0007 |
| 364 |
LEUKOCYTOSIS |
12 |
0.0007 |
| 365 |
NEPHROGENIC SYSTEMIC FIBROSIS |
2 |
0.0007 |
| 366 |
PLATELET COUNT ABNORMAL |
4 |
0.0007 |
| 367 |
ABDOMINAL HERNIA |
3 |
0.0007 |
| 368 |
TROPONIN INCREASED |
5 |
0.0007 |
| 369 |
PERIPHERAL COLDNESS |
9 |
0.0007 |
| 370 |
IMMUNE THROMBOCYTOPENIA |
3 |
0.0007 |
| 371 |
UROSEPSIS |
6 |
0.0006 |
| 372 |
RENAL FAILURE CHRONIC |
5 |
0.0006 |
| 373 |
OLIGURIA |
4 |
0.0006 |
| 374 |
HEPATIC FUNCTION ABNORMAL |
24 |
0.0006 |
| 375 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 376 |
DRUG EFFECT INCREASED |
2 |
0.0006 |
| 377 |
THERAPEUTIC RESPONSE CHANGED |
4 |
0.0006 |
| 378 |
TRICUSPID VALVE INCOMPETENCE |
5 |
0.0006 |
| 379 |
ATRIAL FLUTTER |
5 |
0.0006 |
| 380 |
EXPOSURE TO TOXIC AGENT |
2 |
0.0006 |
| 381 |
ENTEROCOCCAL INFECTION |
3 |
0.0006 |
| 382 |
FLUID OVERLOAD |
9 |
0.0006 |
| 383 |
RESPIRATORY DISTRESS |
17 |
0.0006 |
| 384 |
ANGINA UNSTABLE |
4 |
0.0006 |
| 385 |
DECUBITUS ULCER |
5 |
0.0006 |
| 386 |
STAPHYLOCOCCAL SEPSIS |
3 |
0.0006 |
| 387 |
INCORRECT DRUG ADMINISTRATION DURATION |
17 |
0.0006 |
| 388 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
2 |
0.0006 |
| 389 |
ANEURYSM |
3 |
0.0006 |
| 390 |
HYPERNATRAEMIA |
3 |
0.0006 |
| 391 |
CEREBRAL HAEMATOMA |
2 |
0.0006 |
| 392 |
ULCER HAEMORRHAGE |
4 |
0.0006 |
| 393 |
HEMIPARESIS |
10 |
0.0006 |
| 394 |
CORONARY ARTERY OCCLUSION |
8 |
0.0006 |
| 395 |
PERIPHERAL VASCULAR DISORDER |
3 |
0.0006 |
| 396 |
UNRESPONSIVE TO STIMULI |
15 |
0.0006 |
| 397 |
COLITIS |
22 |
0.0006 |
| 398 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
2 |
0.0006 |
| 399 |
TRANSFUSION |
6 |
0.0006 |
| 400 |
CAROTID ARTERY STENOSIS |
2 |
0.0006 |
| 401 |
RESPIRATORY DEPRESSION |
7 |
0.0006 |
| 402 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
9 |
0.0006 |
| 403 |
DEPRESSIVE SYMPTOM |
2 |
0.0006 |
| 404 |
HAEMORRHAGE SUBCUTANEOUS |
2 |
0.0006 |
| 405 |
LIQUID PRODUCT PHYSICAL ISSUE |
4 |
0.0005 |
| 406 |
STAPHYLOCOCCAL INFECTION |
18 |
0.0005 |
| 407 |
DRUG LEVEL BELOW THERAPEUTIC |
3 |
0.0005 |
| 408 |
BLOOD UREA INCREASED |
9 |
0.0005 |
| 409 |
PRODUCT USE ISSUE |
101 |
0.0005 |
| 410 |
RECTAL HAEMORRHAGE |
23 |
0.0005 |
| 411 |
THERAPEUTIC RESPONSE UNEXPECTED |
24 |
0.0005 |
| 412 |
ACUTE PULMONARY OEDEMA |
3 |
0.0005 |
| 413 |
COLECTOMY |
3 |
0.0005 |
| 414 |
CIRCULATORY COLLAPSE |
9 |
0.0005 |
| 415 |
PARANASAL SINUS DISCOMFORT |
2 |
0.0005 |
| 416 |
ACIDOSIS |
4 |
0.0005 |
| 417 |
SUPRAVENTRICULAR TACHYCARDIA |
5 |
0.0005 |
| 418 |
APNOEA |
4 |
0.0005 |
| 419 |
THROMBOTIC MICROANGIOPATHY |
5 |
0.0005 |
| 420 |
CARDIOPULMONARY FAILURE |
2 |
0.0005 |
| 421 |
PLATELET COUNT DECREASED |
54 |
0.0005 |
| 422 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
36 |
0.0005 |
| 423 |
BACTERAEMIA |
6 |
0.0005 |
| 424 |
BLOOD ALBUMIN DECREASED |
4 |
0.0005 |
| 425 |
HEPATIC FAILURE |
15 |
0.0005 |
| 426 |
HAEMATURIA |
17 |
0.0005 |
| 427 |
MYASTHENIA GRAVIS |
4 |
0.0005 |
| 428 |
HYPOTHERMIA |
5 |
0.0005 |
| 429 |
PRESYNCOPE |
12 |
0.0005 |
| 430 |
ATRIAL FIBRILLATION |
48 |
0.0005 |
| 431 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
27 |
0.0005 |
| 432 |
PARALYSIS |
7 |
0.0005 |
| 433 |
ABNORMAL FAECES |
4 |
0.0005 |
| 434 |
HAEMOGLOBIN DECREASED |
50 |
0.0005 |
| 435 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 436 |
AORTIC DISSECTION |
2 |
0.0005 |
| 437 |
LIVER FUNCTION TEST ABNORMAL |
14 |
0.0005 |
| 438 |
BLOOD BILIRUBIN INCREASED |
13 |
0.0005 |
| 439 |
PRE-EXISTING CONDITION IMPROVED |
3 |
0.0005 |
| 440 |
CARDIO-RESPIRATORY ARREST |
20 |
0.0005 |
| 441 |
LIVE BIRTH |
4 |
0.0005 |
| 442 |
DRUG EFFECT LESS THAN EXPECTED |
7 |
0.0005 |
| 443 |
ESCHERICHIA URINARY TRACT INFECTION |
2 |
0.0005 |
| 444 |
AORTIC VALVE INCOMPETENCE |
2 |
0.0005 |
| 445 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 446 |
PRODUCT PREPARATION ISSUE |
3 |
0.0005 |
| 447 |
SKIN DISCOLOURATION |
21 |
0.0005 |
| 448 |
MELANOCYTIC NAEVUS |
2 |
0.0005 |
| 449 |
SPINAL OSTEOARTHRITIS |
4 |
0.0005 |
| 450 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 451 |
EPISTAXIS |
34 |
0.0005 |
| 452 |
HAEMATOCRIT DECREASED |
9 |
0.0005 |
| 453 |
ABDOMINAL ABSCESS |
2 |
0.0005 |
| 454 |
ASPARTATE AMINOTRANSFERASE INCREASED |
24 |
0.0005 |
| 455 |
EJECTION FRACTION DECREASED |
7 |
0.0004 |
| 456 |
CYTOMEGALOVIRUS VIRAEMIA |
2 |
0.0004 |
| 457 |
HAEMOLYTIC ANAEMIA |
4 |
0.0004 |
| 458 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
11 |
0.0004 |
| 459 |
MITRAL VALVE INCOMPETENCE |
5 |
0.0004 |
| 460 |
ACUTE HEPATIC FAILURE |
6 |
0.0004 |
| 461 |
ECCHYMOSIS |
3 |
0.0004 |
| 462 |
DISEASE COMPLICATION |
2 |
0.0004 |
| 463 |
PERITONITIS |
9 |
0.0004 |
| 464 |
DRUG INEFFECTIVE |
569 |
0.0004 |
| 465 |
CONTRAINDICATED PRODUCT ADMINISTERED |
13 |
0.0004 |
| 466 |
THERAPEUTIC RESPONSE DECREASED |
26 |
0.0004 |
| 467 |
PLEURAL EFFUSION |
26 |
0.0004 |
| 468 |
DUODENAL ULCER |
3 |
0.0004 |
| 469 |
SINUS TACHYCARDIA |
6 |
0.0004 |
| 470 |
HYPOTENSION |
84 |
0.0004 |
| 471 |
ANHEDONIA |
11 |
0.0004 |
| 472 |
KIDNEY TRANSPLANT REJECTION |
2 |
0.0004 |
| 473 |
APHAGIA |
2 |
0.0004 |
| 474 |
UTERINE LEIOMYOMA |
3 |
0.0004 |
| 475 |
HAEMORRHOIDAL HAEMORRHAGE |
2 |
0.0004 |
| 476 |
INCORRECT DOSAGE ADMINISTERED |
2 |
0.0004 |
| 477 |
LIVER INJURY |
10 |
0.0004 |
| 478 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0004 |
| 479 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 480 |
ABDOMINAL TENDERNESS |
2 |
0.0004 |
| 481 |
FLUID INTAKE REDUCED |
2 |
0.0004 |
| 482 |
EOSINOPHILIA |
7 |
0.0004 |
| 483 |
COLD SWEAT |
7 |
0.0004 |
| 484 |
MENTAL STATUS CHANGES |
11 |
0.0004 |
| 485 |
KLEBSIELLA INFECTION |
2 |
0.0004 |
| 486 |
DYSLIPIDAEMIA |
2 |
0.0004 |
| 487 |
THIRST |
7 |
0.0004 |
| 488 |
LIPASE INCREASED |
3 |
0.0004 |
| 489 |
FEMORAL NECK FRACTURE |
2 |
0.0004 |
| 490 |
HAEMOLYSIS |
3 |
0.0004 |
| 491 |
HYPERBILIRUBINAEMIA |
4 |
0.0004 |
| 492 |
FAILURE TO THRIVE |
2 |
0.0004 |
| 493 |
PETECHIAE |
4 |
0.0004 |
| 494 |
PRODUCT ADMINISTRATION INTERRUPTED |
3 |
0.0004 |
| 495 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 496 |
THROAT IRRITATION |
17 |
0.0004 |
| 497 |
PRODUCT PRESCRIBING ERROR |
9 |
0.0004 |
| 498 |
LOW BIRTH WEIGHT BABY |
3 |
0.0004 |
| 499 |
ULCER |
6 |
0.0004 |
| 500 |
AGRANULOCYTOSIS |
7 |
0.0004 |
| 501 |
ALANINE AMINOTRANSFERASE INCREASED |
23 |
0.0004 |
| 502 |
TRANSPLANT REJECTION |
3 |
0.0004 |
| 503 |
FEAR |
10 |
0.0004 |
| 504 |
BLOOD SODIUM DECREASED |
7 |
0.0004 |
| 505 |
ANAL ABSCESS |
2 |
0.0004 |
| 506 |
FREQUENT BOWEL MOVEMENTS |
10 |
0.0004 |
| 507 |
ALTERED STATE OF CONSCIOUSNESS |
8 |
0.0004 |
| 508 |
GASTRIC ULCER |
7 |
0.0004 |
| 509 |
NORMAL NEWBORN |
2 |
0.0004 |
| 510 |
TACHYPNOEA |
5 |
0.0004 |
| 511 |
SEPSIS |
41 |
0.0004 |
| 512 |
PREMATURE BABY |
11 |
0.0004 |
| 513 |
ASPIRATION |
4 |
0.0004 |
| 514 |
ABDOMINAL DISTENSION |
38 |
0.0004 |
| 515 |
CORONARY ARTERY DISEASE |
11 |
0.0004 |
| 516 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
| 517 |
ACUTE CORONARY SYNDROME |
3 |
0.0004 |
| 518 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
0.0004 |
| 519 |
RASH MACULO-PAPULAR |
8 |
0.0004 |
| 520 |
HYPOMAGNESAEMIA |
5 |
0.0004 |
| 521 |
BRADYCARDIA |
19 |
0.0004 |
| 522 |
ATRIAL SEPTAL DEFECT |
3 |
0.0004 |
| 523 |
MALNUTRITION |
4 |
0.0004 |
| 524 |
RENAL IMPAIRMENT |
30 |
0.0004 |
| 525 |
ABDOMINAL PAIN LOWER |
9 |
0.0004 |
| 526 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 527 |
DEVICE OCCLUSION |
5 |
0.0004 |
| 528 |
RENAL FAILURE |
47 |
0.0004 |
| 529 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
6 |
0.0004 |
| 530 |
ANURIA |
3 |
0.0003 |
| 531 |
HERPES VIRUS INFECTION |
2 |
0.0003 |
| 532 |
BLOOD URIC ACID INCREASED |
2 |
0.0003 |
| 533 |
BLOOD PRESSURE DECREASED |
23 |
0.0003 |
| 534 |
HYPERVENTILATION |
2 |
0.0003 |
| 535 |
METABOLIC DISORDER |
2 |
0.0003 |
| 536 |
ANAPHYLACTIC REACTION |
19 |
0.0003 |
| 537 |
URINE OUTPUT DECREASED |
3 |
0.0003 |
| 538 |
LACTIC ACIDOSIS |
11 |
0.0003 |
| 539 |
WHITE BLOOD CELL COUNT INCREASED |
13 |
0.0003 |
| 540 |
RESPIRATORY RATE INCREASED |
3 |
0.0003 |
| 541 |
CARDIAC FAILURE |
27 |
0.0003 |
| 542 |
RHABDOMYOLYSIS |
14 |
0.0003 |
| 543 |
PULMONARY OEDEMA |
15 |
0.0003 |
| 544 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 545 |
TREATMENT NONCOMPLIANCE |
18 |
0.0003 |
| 546 |
DEVICE FAILURE |
5 |
0.0003 |
| 547 |
DISCOMFORT |
20 |
0.0003 |
| 548 |
HAEMATOCHEZIA |
18 |
0.0003 |
| 549 |
DRUG ADMINISTRATION ERROR |
10 |
0.0003 |
| 550 |
GLOMERULAR FILTRATION RATE DECREASED |
4 |
0.0003 |
| 551 |
LARYNGEAL OEDEMA |
2 |
0.0003 |
| 552 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 553 |
FEELING COLD |
9 |
0.0003 |
| 554 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 555 |
DEFORMITY |
3 |
0.0003 |
| 556 |
CYANOSIS |
5 |
0.0003 |
| 557 |
DELIRIUM |
11 |
0.0003 |
| 558 |
ANAEMIA |
60 |
0.0003 |
| 559 |
FOREIGN BODY SENSATION IN EYES |
2 |
0.0003 |
| 560 |
INJURY |
22 |
0.0003 |
| 561 |
OFF LABEL USE |
274 |
0.0003 |
| 562 |
ENTERITIS |
2 |
0.0003 |
| 563 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
2 |
0.0003 |
| 564 |
PRODUCT USE IN UNAPPROVED INDICATION |
77 |
0.0003 |
| 565 |
ANAPHYLACTIC SHOCK |
8 |
0.0003 |
| 566 |
HEART RATE IRREGULAR |
7 |
0.0003 |
| 567 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 568 |
HEPATOMEGALY |
3 |
0.0003 |
| 569 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
12 |
0.0003 |
| 570 |
ADVERSE REACTION |
4 |
0.0003 |
| 571 |
RESPIRATORY DISORDER |
9 |
0.0003 |
| 572 |
LIP SWELLING |
10 |
0.0003 |
| 573 |
OVARIAN CYST |
3 |
0.0003 |
| 574 |
BRAIN INJURY |
3 |
0.0003 |
| 575 |
VOMITING |
140 |
0.0003 |
| 576 |
THROAT TIGHTNESS |
8 |
0.0003 |
| 577 |
DRUG TOXICITY |
4 |
0.0003 |
| 578 |
INCORRECT DOSE ADMINISTERED |
67 |
0.0003 |
| 579 |
LIVER DISORDER |
13 |
0.0003 |
| 580 |
NEUTROPHIL COUNT INCREASED |
3 |
0.0003 |
| 581 |
BLOOD CREATININE INCREASED |
19 |
0.0003 |
| 582 |
VENTRICULAR EXTRASYSTOLES |
3 |
0.0003 |
| 583 |
TENDERNESS |
3 |
0.0003 |
| 584 |
HYPERKALAEMIA |
10 |
0.0003 |
| 585 |
PAPULE |
2 |
0.0003 |
| 586 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 587 |
LYMPHOCYTE COUNT DECREASED |
5 |
0.0003 |
| 588 |
HYPOKALAEMIA |
13 |
0.0003 |
| 589 |
PNEUMONIA ASPIRATION |
7 |
0.0003 |
| 590 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
2 |
0.0003 |
| 591 |
IMPAIRED QUALITY OF LIFE |
4 |
0.0003 |
| 592 |
SKIN LACERATION |
3 |
0.0003 |
| 593 |
FAECES SOFT |
2 |
0.0003 |
| 594 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
7 |
0.0003 |
| 595 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
3 |
0.0003 |
| 596 |
HYPOPHOSPHATAEMIA |
2 |
0.0003 |
| 597 |
MEDICAL DEVICE COMPLICATION |
2 |
0.0003 |
| 598 |
MEDICATION ERROR |
15 |
0.0003 |
| 599 |
DRUG DEPENDENCE |
43 |
0.0003 |
| 600 |
BLISTER |
15 |
0.0003 |
| 601 |
TRANSIENT ISCHAEMIC ATTACK |
9 |
0.0003 |
| 602 |
TREATMENT FAILURE |
22 |
0.0003 |
| 603 |
APHASIA |
8 |
0.0003 |
| 604 |
INTERNAL HAEMORRHAGE |
3 |
0.0003 |
| 605 |
CARDIAC FAILURE CONGESTIVE |
21 |
0.0003 |
| 606 |
ACUTE KIDNEY INJURY |
40 |
0.0003 |
| 607 |
BOWEL MOVEMENT IRREGULARITY |
2 |
0.0003 |
| 608 |
MUSCLE TWITCHING |
6 |
0.0003 |
| 609 |
ATRIOVENTRICULAR BLOCK |
2 |
0.0003 |
| 610 |
MATERNAL EXPOSURE DURING PREGNANCY |
23 |
0.0003 |
| 611 |
VASCULITIS |
3 |
0.0003 |
| 612 |
HYPOALBUMINAEMIA |
2 |
0.0003 |
| 613 |
GASTROINTESTINAL INFLAMMATION |
2 |
0.0003 |
| 614 |
ARTERIAL OCCLUSIVE DISEASE |
2 |
0.0003 |
| 615 |
DYSPEPSIA |
25 |
0.0003 |
| 616 |
COVID-19 PNEUMONIA |
3 |
0.0003 |
| 617 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
9 |
0.0003 |
| 618 |
LOSS OF CONSCIOUSNESS |
32 |
0.0002 |
| 619 |
BLOOD DISORDER |
2 |
0.0002 |
| 620 |
OXYGEN SATURATION DECREASED |
14 |
0.0002 |
| 621 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
9 |
0.0002 |
| 622 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 623 |
MUSCLE DISORDER |
2 |
0.0002 |
| 624 |
SMALL INTESTINAL OBSTRUCTION |
3 |
0.0002 |
| 625 |
EYE DISORDER |
8 |
0.0002 |
| 626 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 627 |
MYOCARDIAL INFARCTION |
42 |
0.0002 |
| 628 |
INJECTION SITE DISCOLOURATION |
3 |
0.0002 |
| 629 |
DYSARTHRIA |
9 |
0.0002 |
| 630 |
ASCITES |
7 |
0.0002 |
| 631 |
UNEVALUABLE EVENT |
18 |
0.0002 |
| 632 |
ABDOMINAL PAIN |
55 |
0.0002 |
| 633 |
TACHYCARDIA |
21 |
0.0002 |
| 634 |
GASTROINTESTINAL DISORDER |
21 |
0.0002 |
| 635 |
SCAR |
4 |
0.0002 |
| 636 |
DEHYDRATION |
31 |
0.0002 |
| 637 |
SKIN ULCER |
6 |
0.0002 |
| 638 |
DISEASE RECURRENCE |
11 |
0.0002 |
| 639 |
HYSTERECTOMY |
2 |
0.0002 |
| 640 |
HYPONATRAEMIA |
13 |
0.0002 |
| 641 |
SWELLING FACE |
15 |
0.0002 |
| 642 |
BLOOD CALCIUM INCREASED |
2 |
0.0002 |
| 643 |
DRUG INTERACTION |
36 |
0.0002 |
| 644 |
CHEST PAIN |
42 |
0.0002 |
| 645 |
JOINT RANGE OF MOTION DECREASED |
3 |
0.0002 |
| 646 |
GASTROOESOPHAGEAL REFLUX DISEASE |
18 |
0.0002 |
| 647 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 648 |
PALLOR |
6 |
0.0002 |
| 649 |
IMPAIRED GASTRIC EMPTYING |
3 |
0.0002 |
| 650 |
GINGIVAL BLEEDING |
3 |
0.0002 |
| 651 |
PATHOGEN RESISTANCE |
2 |
0.0002 |
| 652 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 653 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 654 |
NERVE COMPRESSION |
2 |
0.0002 |
| 655 |
POLLAKIURIA |
9 |
0.0002 |
| 656 |
EYE SWELLING |
8 |
0.0002 |
| 657 |
MASS |
3 |
0.0002 |
| 658 |
NEPHROPATHY |
2 |
0.0002 |
| 659 |
FLANK PAIN |
2 |
0.0002 |
| 660 |
OSTEONECROSIS |
7 |
0.0002 |
| 661 |
PHOTOPHOBIA |
4 |
0.0002 |
| 662 |
FLATULENCE |
12 |
0.0002 |
| 663 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 664 |
ARRHYTHMIA |
10 |
0.0002 |
| 665 |
BLOOD URINE PRESENT |
4 |
0.0002 |
| 666 |
URTICARIA |
35 |
0.0002 |
| 667 |
PULMONARY FIBROSIS |
4 |
0.0002 |
| 668 |
PRODUCT SUBSTITUTION ISSUE |
12 |
0.0002 |
| 669 |
PARAESTHESIA ORAL |
3 |
0.0002 |
| 670 |
VAGINAL HAEMORRHAGE |
9 |
0.0002 |
| 671 |
HYPOKINESIA |
3 |
0.0002 |
| 672 |
COMPLICATION ASSOCIATED WITH DEVICE |
3 |
0.0002 |
| 673 |
NAUSEA |
162 |
0.0002 |
| 674 |
ABDOMINAL PAIN UPPER |
42 |
0.0002 |
| 675 |
GASTRIC DISORDER |
7 |
0.0002 |
| 676 |
ENCEPHALOPATHY |
5 |
0.0002 |
| 677 |
DISABILITY |
4 |
0.0002 |
| 678 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
9 |
0.0002 |
| 679 |
THERAPY NON-RESPONDER |
9 |
0.0002 |
| 680 |
HYPOAESTHESIA ORAL |
3 |
0.0002 |
| 681 |
ECONOMIC PROBLEM |
3 |
0.0002 |
| 682 |
NECK PAIN |
11 |
0.0002 |
| 683 |
BLOOD PRESSURE INCREASED |
30 |
0.0002 |
| 684 |
RENAL DISORDER |
9 |
0.0002 |
| 685 |
EXPOSURE DURING PREGNANCY |
12 |
0.0002 |
| 686 |
THERAPY PARTIAL RESPONDER |
3 |
0.0002 |
| 687 |
SWOLLEN TONGUE |
6 |
0.0002 |
| 688 |
UNDERDOSE |
14 |
0.0002 |
| 689 |
RESTLESSNESS |
7 |
0.0002 |
| 690 |
GASTRITIS |
5 |
0.0002 |
| 691 |
INCONTINENCE |
2 |
0.0002 |
| 692 |
COMA |
9 |
0.0002 |
| 693 |
CEREBROVASCULAR ACCIDENT |
32 |
0.0002 |
| 694 |
PNEUMONIA |
61 |
0.0002 |
| 695 |
CHILLS |
22 |
0.0002 |
| 696 |
METABOLIC ACIDOSIS |
6 |
0.0002 |
| 697 |
CHEST DISCOMFORT |
19 |
0.0002 |
| 698 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 699 |
MUSCLE TIGHTNESS |
3 |
0.0002 |
| 700 |
OEDEMA |
10 |
0.0002 |
| 701 |
LUNG DISORDER |
9 |
0.0002 |
| 702 |
OESOPHAGITIS |
2 |
0.0002 |
| 703 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 704 |
CONDITION AGGRAVATED |
55 |
0.0002 |
| 705 |
EXPIRED PRODUCT ADMINISTERED |
6 |
0.0002 |
| 706 |
SYNCOPE |
18 |
0.0002 |
| 707 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 708 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 709 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 710 |
CHROMATURIA |
4 |
0.0002 |
| 711 |
DISORIENTATION |
7 |
0.0002 |
| 712 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 713 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
3 |
0.0002 |
| 714 |
RED BLOOD CELL COUNT DECREASED |
5 |
0.0002 |
| 715 |
CONVULSION |
10 |
0.0002 |
| 716 |
ILLNESS |
18 |
0.0002 |
| 717 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
5 |
0.0002 |
| 718 |
EYELID OEDEMA |
2 |
0.0002 |
| 719 |
SPEECH DISORDER |
9 |
0.0002 |
| 720 |
PRODUCT STORAGE ERROR |
15 |
0.0002 |
| 721 |
DYSSTASIA |
5 |
0.0002 |
| 722 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0002 |
| 723 |
LYMPHADENOPATHY |
6 |
0.0002 |
| 724 |
HEAD DISCOMFORT |
3 |
0.0002 |
| 725 |
DYSPHAGIA |
16 |
0.0002 |
| 726 |
RENAL INJURY |
5 |
0.0002 |
| 727 |
MUSCLE RIGIDITY |
2 |
0.0002 |
| 728 |
HYPERSENSITIVITY |
31 |
0.0002 |
| 729 |
DIARRHOEA |
107 |
0.0002 |
| 730 |
OSTEOMYELITIS |
3 |
0.0002 |
| 731 |
EPILEPSY |
5 |
0.0002 |
| 732 |
CONJUNCTIVITIS |
3 |
0.0002 |
| 733 |
HEPATIC ENZYME INCREASED |
11 |
0.0002 |
| 734 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 735 |
BACTERIAL INFECTION |
3 |
0.0002 |
| 736 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 737 |
LEUKOPENIA |
8 |
0.0002 |
| 738 |
FOETAL EXPOSURE DURING PREGNANCY |
13 |
0.0002 |
| 739 |
PRODUCT COMPLAINT |
4 |
0.0002 |
| 740 |
CARDIOVASCULAR DISORDER |
4 |
0.0002 |
| 741 |
FEELING JITTERY |
3 |
0.0002 |
| 742 |
CHOLESTASIS |
3 |
0.0002 |
| 743 |
GENERAL PHYSICAL HEALTH DETERIORATION |
18 |
0.0002 |
| 744 |
HYPERHIDROSIS |
20 |
0.0002 |
| 745 |
PRESCRIBED OVERDOSE |
3 |
0.0002 |
| 746 |
PRODUCT QUALITY ISSUE |
21 |
0.0002 |
| 747 |
HIATUS HERNIA |
2 |
0.0002 |
| 748 |
DYSPHONIA |
9 |
0.0002 |
| 749 |
AMNESIA |
10 |
0.0002 |
| 750 |
NODULE |
2 |
0.0002 |
| 751 |
DEAFNESS |
4 |
0.0002 |
| 752 |
JOINT STIFFNESS |
4 |
0.0002 |
| 753 |
BEDRIDDEN |
2 |
0.0002 |
| 754 |
IMMUNE SYSTEM DISORDER |
2 |
0.0002 |
| 755 |
HEART RATE INCREASED |
15 |
0.0002 |
| 756 |
URINARY RETENTION |
5 |
0.0001 |
| 757 |
AGITATION |
11 |
0.0001 |
| 758 |
GAIT INABILITY |
5 |
0.0001 |
| 759 |
SWELLING |
14 |
0.0001 |
| 760 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 761 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 762 |
TASTE DISORDER |
3 |
0.0001 |
| 763 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 764 |
HEADACHE |
92 |
0.0001 |
| 765 |
SKIN LESION |
4 |
0.0001 |
| 766 |
RESPIRATORY ARREST |
4 |
0.0001 |
| 767 |
CHRONIC KIDNEY DISEASE |
11 |
0.0001 |
| 768 |
OVERDOSE |
31 |
0.0001 |
| 769 |
DYSPNOEA |
81 |
0.0001 |
| 770 |
HALLUCINATION, VISUAL |
3 |
0.0001 |
| 771 |
BLINDNESS UNILATERAL |
2 |
0.0001 |
| 772 |
HEPATOCELLULAR INJURY |
2 |
0.0001 |
| 773 |
EATING DISORDER |
3 |
0.0001 |
| 774 |
JOINT INJURY |
3 |
0.0001 |
| 775 |
BRONCHOSPASM |
2 |
0.0001 |
| 776 |
ANGINA PECTORIS |
4 |
0.0001 |
| 777 |
CELLULITIS |
7 |
0.0001 |
| 778 |
TREMOR |
23 |
0.0001 |
| 779 |
SEIZURE |
16 |
0.0001 |
| 780 |
C-REACTIVE PROTEIN INCREASED |
5 |
0.0001 |
| 781 |
ANXIETY |
39 |
0.0001 |
| 782 |
ACCIDENTAL OVERDOSE |
5 |
0.0001 |
| 783 |
MUSCLE SPASMS |
25 |
0.0001 |
| 784 |
STEVENS-JOHNSON SYNDROME |
3 |
0.0001 |
| 785 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 786 |
URINARY TRACT INFECTION |
23 |
0.0001 |
| 787 |
COLON CANCER |
2 |
0.0001 |
| 788 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
7 |
0.0001 |
| 789 |
PANCREATITIS ACUTE |
3 |
0.0001 |
| 790 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 791 |
INTESTINAL OBSTRUCTION |
5 |
0.0001 |
| 792 |
HYPERTENSION |
28 |
0.0001 |
| 793 |
OSTEOPENIA |
2 |
0.0001 |
| 794 |
ERYTHEMA |
27 |
0.0001 |
| 795 |
OEDEMA PERIPHERAL |
16 |
0.0001 |
| 796 |
ABDOMINAL DISCOMFORT |
22 |
0.0001 |
| 797 |
DRUG DISPENSING ERROR |
2 |
0.0001 |
| 798 |
NEPHROLITHIASIS |
6 |
0.0001 |
| 799 |
TINNITUS |
6 |
0.0001 |
| 800 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 801 |
LUNG INFECTION |
2 |
0.0001 |
| 802 |
CONSTIPATION |
28 |
0.0001 |
| 803 |
PALPITATIONS |
15 |
0.0001 |
| 804 |
DRUG-INDUCED LIVER INJURY |
4 |
0.0001 |
| 805 |
DIZZINESS |
63 |
0.0001 |
| 806 |
HALLUCINATION, AUDITORY |
2 |
0.0001 |
| 807 |
INTENTIONAL PRODUCT MISUSE |
11 |
0.0001 |
| 808 |
CYSTITIS |
4 |
0.0001 |
| 809 |
ABSCESS |
2 |
0.0001 |
| 810 |
BLOOD PRESSURE FLUCTUATION |
3 |
0.0001 |
| 811 |
MENTAL IMPAIRMENT |
3 |
0.0001 |
| 812 |
EXTRA DOSE ADMINISTERED |
5 |
0.0001 |
| 813 |
MUSCULAR WEAKNESS |
14 |
0.0001 |
| 814 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 815 |
BLINDNESS |
5 |
0.0001 |
| 816 |
CHOLELITHIASIS |
4 |
0.0001 |
| 817 |
IMPAIRED HEALING |
4 |
0.0001 |
| 818 |
FEBRILE NEUTROPENIA |
8 |
0.0001 |
| 819 |
VIRAL INFECTION |
4 |
0.0001 |
| 820 |
PAIN IN EXTREMITY |
35 |
0.0001 |
| 821 |
CANDIDA INFECTION |
2 |
0.0001 |
| 822 |
DISEASE PROGRESSION |
14 |
0.0001 |
| 823 |
DIABETES MELLITUS |
9 |
0.0001 |
| 824 |
CONFUSIONAL STATE |
19 |
0.0001 |
| 825 |
HYPOPHAGIA |
3 |
0.0001 |
| 826 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 827 |
PYREXIA |
40 |
0.0001 |
| 828 |
DIPLOPIA |
3 |
0.0001 |
| 829 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 830 |
LOCAL SWELLING |
2 |
0.0001 |
| 831 |
MUSCULOSKELETAL PAIN |
6 |
0.0001 |
| 832 |
BURNING SENSATION |
8 |
0.0001 |
| 833 |
HEART RATE DECREASED |
4 |
0.0001 |
| 834 |
ANGIOEDEMA |
5 |
0.0001 |
| 835 |
GALLBLADDER DISORDER |
2 |
0.0001 |
| 836 |
MALAISE |
49 |
0.0001 |
| 837 |
DRUG EFFECT DECREASED |
6 |
0.0001 |
| 838 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 839 |
LIMB INJURY |
3 |
0.0001 |
| 840 |
DRUG EFFECT INCOMPLETE |
4 |
0.0001 |
| 841 |
BONE DISORDER |
2 |
0.0001 |
| 842 |
PANIC ATTACK |
4 |
0.0001 |
| 843 |
PROCEDURAL PAIN |
3 |
0.0001 |
| 844 |
BRONCHITIS |
8 |
0.0001 |
| 845 |
PARAESTHESIA |
17 |
0.0001 |
| 846 |
PAIN |
65 |
0.0001 |
| 847 |
MUSCULOSKELETAL DISORDER |
2 |
0.0001 |
| 848 |
NO ADVERSE EVENT |
19 |
0.0001 |
| 849 |
RASH ERYTHEMATOUS |
5 |
0.0001 |
| 850 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 851 |
CONTUSION |
10 |
0.0001 |
| 852 |
HERNIA |
2 |
0.0001 |
| 853 |
HAEMORRHOIDS |
2 |
0.0001 |
| 854 |
LABORATORY TEST ABNORMAL |
3 |
0.0001 |
| 855 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 856 |
INSOMNIA |
27 |
0.0001 |
| 857 |
WHEEZING |
6 |
0.0001 |
| 858 |
RASH |
44 |
0.0001 |
| 859 |
HYPOAESTHESIA |
15 |
0.0001 |
| 860 |
FEELING ABNORMAL |
24 |
0.0001 |
| 861 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 862 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 863 |
CARDIAC DISORDER |
9 |
0.0001 |
| 864 |
NERVOUSNESS |
5 |
0.0001 |
| 865 |
INTENTIONAL DRUG MISUSE |
2 |
0.0001 |
| 866 |
NEUTROPENIA |
13 |
0.0001 |
| 867 |
BLOOD GLUCOSE INCREASED |
18 |
0.0001 |
| 868 |
DERMATITIS |
2 |
0.0001 |
| 869 |
SKIN EXFOLIATION |
8 |
0.0001 |
| 870 |
MIGRAINE |
9 |
0.0001 |
| 871 |
DYSGEUSIA |
7 |
0.0001 |
| 872 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 873 |
IMPAIRED WORK ABILITY |
2 |
0.0001 |
| 874 |
HALLUCINATION |
7 |
0.0001 |
| 875 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 876 |
MENTAL DISORDER |
4 |
0.0001 |
| 877 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 878 |
EMOTIONAL DISTRESS |
11 |
0.0001 |
| 879 |
INFUSION RELATED REACTION |
6 |
0.0001 |
| 880 |
SKIN DISORDER |
3 |
0.0001 |
| 881 |
HEPATOTOXICITY |
2 |
0.0001 |
| 882 |
COLITIS ULCERATIVE |
4 |
0.0001 |
| 883 |
ORAL PAIN |
2 |
0.0001 |
| 884 |
DEATH |
76 |
0.0001 |
| 885 |
DECREASED APPETITE |
20 |
0.0001 |
| 886 |
COGNITIVE DISORDER |
4 |
0.0001 |
| 887 |
SLEEP DISORDER |
6 |
0.0001 |
| 888 |
PERIPHERAL SWELLING |
13 |
0.0001 |
| 889 |
OCULAR HYPERAEMIA |
4 |
0.0001 |
| 890 |
ELECTROCARDIOGRAM QT PROLONGED |
3 |
0.0001 |
| 891 |
INTERSTITIAL LUNG DISEASE |
4 |
0.0001 |
| 892 |
HYPOGLYCAEMIA |
4 |
0.0001 |
| 893 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 894 |
NEURALGIA |
2 |
0.0001 |
| 895 |
VERTIGO |
5 |
0.0001 |
| 896 |
BACK PAIN |
19 |
0.0001 |
| 897 |
FEELING HOT |
5 |
0.0001 |
| 898 |
PRURITUS |
31 |
0.0001 |
| 899 |
VISION BLURRED |
11 |
0.0001 |
| 900 |
INTENTIONAL PRODUCT USE ISSUE |
7 |
0.0001 |
| 901 |
ASTHMA |
9 |
0.0001 |
| 902 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 903 |
INFLAMMATION |
4 |
0.0001 |
| 904 |
ASTHENIA |
29 |
0.0001 |
| 905 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 906 |
DERMATITIS ATOPIC |
4 |
0.0001 |
| 907 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 908 |
COUGH |
21 |
0.0001 |
| 909 |
JAUNDICE |
2 |
0.0001 |
| 910 |
PAIN OF SKIN |
2 |
0.0001 |
| 911 |
GAIT DISTURBANCE |
14 |
0.0001 |
| 912 |
DEPENDENCE |
4 |
0.0001 |
| 913 |
DRUG INTOLERANCE |
7 |
0.0001 |
| 914 |
PANCYTOPENIA |
4 |
0.0001 |
| 915 |
DEMENTIA |
2 |
0.0001 |
| 916 |
WEIGHT INCREASED |
16 |
0.0001 |
| 917 |
DEVICE MALFUNCTION |
5 |
0.0001 |
| 918 |
LETHARGY |
4 |
0.0001 |
| 919 |
FLUSHING |
7 |
0.0001 |
| 920 |
BONE PAIN |
4 |
0.0001 |
| 921 |
NASAL CONGESTION |
4 |
0.0001 |
| 922 |
TOXICITY TO VARIOUS AGENTS |
11 |
0.0001 |
| 923 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 924 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 925 |
FEMUR FRACTURE |
2 |
0.0001 |
| 926 |
SOMNOLENCE |
13 |
0.0001 |
| 927 |
NERVOUS SYSTEM DISORDER |
2 |
0.0001 |
| 928 |
HEAD INJURY |
2 |
0.0001 |
| 929 |
FALL |
21 |
0.0001 |
| 930 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 931 |
WEIGHT DECREASED |
17 |
0.0001 |
| 932 |
FLUID RETENTION |
3 |
0.0001 |
| 933 |
DRUG EXPOSURE DURING PREGNANCY |
2 |
0.0001 |
| 934 |
DEVICE USE ERROR |
2 |
0.0001 |
| 935 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 936 |
ECZEMA |
3 |
0.0001 |
| 937 |
MUSCULOSKELETAL STIFFNESS |
5 |
0.0001 |
| 938 |
VISUAL IMPAIRMENT |
7 |
0.0001 |
| 939 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 940 |
ALOPECIA |
11 |
0.0001 |
| 941 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 942 |
MOBILITY DECREASED |
4 |
0.0001 |
| 943 |
RASH PRURITIC |
3 |
0.0001 |
| 944 |
WHITE BLOOD CELL COUNT DECREASED |
6 |
0.0001 |
| 945 |
ARTHRALGIA |
23 |
0.0001 |
| 946 |
INFECTION |
8 |
0.0001 |
| 947 |
DYSURIA |
2 |
0.0001 |
| 948 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
11 |
0.0001 |
| 949 |
EYE PAIN |
3 |
0.0001 |
| 950 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 951 |
HOT FLUSH |
4 |
0.0001 |
| 952 |
DEPRESSION |
12 |
0.0001 |
| 953 |
FATIGUE |
41 |
0.0001 |
| 954 |
HERPES ZOSTER |
3 |
0.0001 |
| 955 |
HOSPITALISATION |
8 |
0.0001 |
| 956 |
IRRITABILITY |
3 |
0.0000 |
| 957 |
STOMATITIS |
3 |
0.0000 |
| 958 |
ILL-DEFINED DISORDER |
3 |
0.0000 |
| 959 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 960 |
OSTEOPOROSIS |
2 |
0.0000 |
| 961 |
RHINORRHOEA |
3 |
0.0000 |
| 962 |
BALANCE DISORDER |
4 |
0.0000 |
| 963 |
COVID-19 |
8 |
0.0000 |
| 964 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 965 |
NASOPHARYNGITIS |
8 |
0.0000 |
| 966 |
NEUROPATHY PERIPHERAL |
4 |
0.0000 |
| 967 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 968 |
JOINT SWELLING |
5 |
0.0000 |
| 969 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 970 |
SINUSITIS |
4 |
0.0000 |
| 971 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
7 |
0.0000 |
| 972 |
PANCREATITIS |
2 |
0.0000 |
| 973 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0000 |
| 974 |
DRY SKIN |
5 |
0.0000 |
| 975 |
PROSTATE CANCER |
3 |
0.0000 |
| 976 |
INFLUENZA |
4 |
0.0000 |
| 977 |
MYALGIA |
6 |
0.0000 |
| 978 |
PRODUCT DOSE OMISSION ISSUE |
10 |
0.0000 |
| 979 |
BLADDER CANCER |
2 |
0.0000 |
| 980 |
CATARACT |
2 |
0.0000 |
| 981 |
ADVERSE EVENT |
3 |
0.0000 |
| 982 |
PSORIASIS |
4 |
0.0000 |
| 983 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 984 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 985 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 986 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 987 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 988 |
DRY MOUTH |
2 |
0.0000 |
| 989 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 990 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 991 |
DRUG ABUSE |
2 |
0.0000 |
| 992 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 993 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |